Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat

P. W. Kalivas, S. K. Burgess, Charles Nemeroff, A. J. Prange

Research output: Contribution to journalArticle

183 Citations (Scopus)

Abstract

The ventral tegmental area of the rat brain has been shown to possess high densities of neurotensin- and dopamine-containing neuronal perikarya. We recently demonstrated that microinjection of neurotensin into the ventral tegmental area produces behavioral hyperactivity similar to amphetamine-induced increase in exploratory behaviors, but lacking stereotypies. In this study, we report that the threshold dose for neurotensin-induced hyperactivity is 0.10-0.25 μg neurotensin/side. Either intracerebroventricular injection of haloperidol (5.0 μg/lateral ventricle) or destruction of the mesolimbic dopamine system by 6-hydroxydopamine abolishes the behavioral hyperactivity produced by intraventral tegmental injection of neurotensin (2.5 μg/side). Using high pressure liquid chromatography with electrochemical detection, we show that neurotensin injection into the ventral tegmental area increases the concentration of dopamine metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid in the nucleus accumbens and olfactory tubercles, but not in the striatum. This effect is especially profound in the nucleus accumbens where the threshold dose is less than 0.025 μg/side. The ratio of 3,4-dihydroxyphenylacetic acid to dopamine increased in the nucleus accumbens and olfactory tubercles in a dosedependent fashion (0.025 μg-2.50 μg/side). Neurotensin-induced behavioral hyperactivity correlates positively with neurotensin-induced changes in the ratio of 3,4-dihydroxyphenylacetic acid to dopamine. This study indicates that neurotensin acts in the ventral tegmental area to activate the mesolimbic dopamine system. Further, this activation produces behavioral hyperactivity characterized by an increase in exploratory behaviors. The fact that both immunoreactive neurotensin and neurotensin receptors are found in high concentration in the ventral tegmental area supports the possible physiological significance of this peptide-catecholamine interaction.

Original languageEnglish
Pages (from-to)495-505
Number of pages11
JournalNeuroscience
Volume8
Issue number3
DOIs
StatePublished - Jan 1 1983
Externally publishedYes

Fingerprint

Neurotensin
Ventral Tegmental Area
Microinjections
Dopamine
3,4-Dihydroxyphenylacetic Acid
Nucleus Accumbens
Exploratory Behavior
Injections
Neurotensin Receptors
Homovanillic Acid
Lateral Ventricles
Oxidopamine
Haloperidol
Amphetamine
Catecholamines
High Pressure Liquid Chromatography

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. / Kalivas, P. W.; Burgess, S. K.; Nemeroff, Charles; Prange, A. J.

In: Neuroscience, Vol. 8, No. 3, 01.01.1983, p. 495-505.

Research output: Contribution to journalArticle

@article{5426b2983fb548fbb6657c0562ef8297,
title = "Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat",
abstract = "The ventral tegmental area of the rat brain has been shown to possess high densities of neurotensin- and dopamine-containing neuronal perikarya. We recently demonstrated that microinjection of neurotensin into the ventral tegmental area produces behavioral hyperactivity similar to amphetamine-induced increase in exploratory behaviors, but lacking stereotypies. In this study, we report that the threshold dose for neurotensin-induced hyperactivity is 0.10-0.25 μg neurotensin/side. Either intracerebroventricular injection of haloperidol (5.0 μg/lateral ventricle) or destruction of the mesolimbic dopamine system by 6-hydroxydopamine abolishes the behavioral hyperactivity produced by intraventral tegmental injection of neurotensin (2.5 μg/side). Using high pressure liquid chromatography with electrochemical detection, we show that neurotensin injection into the ventral tegmental area increases the concentration of dopamine metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid in the nucleus accumbens and olfactory tubercles, but not in the striatum. This effect is especially profound in the nucleus accumbens where the threshold dose is less than 0.025 μg/side. The ratio of 3,4-dihydroxyphenylacetic acid to dopamine increased in the nucleus accumbens and olfactory tubercles in a dosedependent fashion (0.025 μg-2.50 μg/side). Neurotensin-induced behavioral hyperactivity correlates positively with neurotensin-induced changes in the ratio of 3,4-dihydroxyphenylacetic acid to dopamine. This study indicates that neurotensin acts in the ventral tegmental area to activate the mesolimbic dopamine system. Further, this activation produces behavioral hyperactivity characterized by an increase in exploratory behaviors. The fact that both immunoreactive neurotensin and neurotensin receptors are found in high concentration in the ventral tegmental area supports the possible physiological significance of this peptide-catecholamine interaction.",
author = "Kalivas, {P. W.} and Burgess, {S. K.} and Charles Nemeroff and Prange, {A. J.}",
year = "1983",
month = "1",
day = "1",
doi = "10.1016/0306-4522(83)90195-1",
language = "English",
volume = "8",
pages = "495--505",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat

AU - Kalivas, P. W.

AU - Burgess, S. K.

AU - Nemeroff, Charles

AU - Prange, A. J.

PY - 1983/1/1

Y1 - 1983/1/1

N2 - The ventral tegmental area of the rat brain has been shown to possess high densities of neurotensin- and dopamine-containing neuronal perikarya. We recently demonstrated that microinjection of neurotensin into the ventral tegmental area produces behavioral hyperactivity similar to amphetamine-induced increase in exploratory behaviors, but lacking stereotypies. In this study, we report that the threshold dose for neurotensin-induced hyperactivity is 0.10-0.25 μg neurotensin/side. Either intracerebroventricular injection of haloperidol (5.0 μg/lateral ventricle) or destruction of the mesolimbic dopamine system by 6-hydroxydopamine abolishes the behavioral hyperactivity produced by intraventral tegmental injection of neurotensin (2.5 μg/side). Using high pressure liquid chromatography with electrochemical detection, we show that neurotensin injection into the ventral tegmental area increases the concentration of dopamine metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid in the nucleus accumbens and olfactory tubercles, but not in the striatum. This effect is especially profound in the nucleus accumbens where the threshold dose is less than 0.025 μg/side. The ratio of 3,4-dihydroxyphenylacetic acid to dopamine increased in the nucleus accumbens and olfactory tubercles in a dosedependent fashion (0.025 μg-2.50 μg/side). Neurotensin-induced behavioral hyperactivity correlates positively with neurotensin-induced changes in the ratio of 3,4-dihydroxyphenylacetic acid to dopamine. This study indicates that neurotensin acts in the ventral tegmental area to activate the mesolimbic dopamine system. Further, this activation produces behavioral hyperactivity characterized by an increase in exploratory behaviors. The fact that both immunoreactive neurotensin and neurotensin receptors are found in high concentration in the ventral tegmental area supports the possible physiological significance of this peptide-catecholamine interaction.

AB - The ventral tegmental area of the rat brain has been shown to possess high densities of neurotensin- and dopamine-containing neuronal perikarya. We recently demonstrated that microinjection of neurotensin into the ventral tegmental area produces behavioral hyperactivity similar to amphetamine-induced increase in exploratory behaviors, but lacking stereotypies. In this study, we report that the threshold dose for neurotensin-induced hyperactivity is 0.10-0.25 μg neurotensin/side. Either intracerebroventricular injection of haloperidol (5.0 μg/lateral ventricle) or destruction of the mesolimbic dopamine system by 6-hydroxydopamine abolishes the behavioral hyperactivity produced by intraventral tegmental injection of neurotensin (2.5 μg/side). Using high pressure liquid chromatography with electrochemical detection, we show that neurotensin injection into the ventral tegmental area increases the concentration of dopamine metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid in the nucleus accumbens and olfactory tubercles, but not in the striatum. This effect is especially profound in the nucleus accumbens where the threshold dose is less than 0.025 μg/side. The ratio of 3,4-dihydroxyphenylacetic acid to dopamine increased in the nucleus accumbens and olfactory tubercles in a dosedependent fashion (0.025 μg-2.50 μg/side). Neurotensin-induced behavioral hyperactivity correlates positively with neurotensin-induced changes in the ratio of 3,4-dihydroxyphenylacetic acid to dopamine. This study indicates that neurotensin acts in the ventral tegmental area to activate the mesolimbic dopamine system. Further, this activation produces behavioral hyperactivity characterized by an increase in exploratory behaviors. The fact that both immunoreactive neurotensin and neurotensin receptors are found in high concentration in the ventral tegmental area supports the possible physiological significance of this peptide-catecholamine interaction.

UR - http://www.scopus.com/inward/record.url?scp=0020573722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020573722&partnerID=8YFLogxK

U2 - 10.1016/0306-4522(83)90195-1

DO - 10.1016/0306-4522(83)90195-1

M3 - Article

C2 - 6406930

AN - SCOPUS:0020573722

VL - 8

SP - 495

EP - 505

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 3

ER -